MariMed Statistics
Total Valuation
MariMed has a market cap or net worth of $103.72 million. The enterprise value is $188.12 million.
| Market Cap | 103.72M |
| Enterprise Value | 188.12M |
Important Dates
The last earnings date was Wednesday, August 2, 2023, after market close.
| Earnings Date | Aug 2, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
MariMed has 375.13 million shares outstanding. The number of shares has decreased by -1.53% in one year.
| Shares Outstanding | 375.13M |
| Shares Change (YoY) | -1.53% |
| Shares Change (QoQ) | +0.78% |
| Owned by Insiders (%) | 16.01% |
| Owned by Institutions (%) | 0.78% |
| Float | 337.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.70 |
| Forward PS | 0.65 |
| PB Ratio | 1.45 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.27 |
| EV / EBITDA | 11.62 |
| EV / EBIT | 24.68 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.67, with a Debt / Equity ratio of 1.39.
| Current Ratio | 1.67 |
| Quick Ratio | 0.77 |
| Debt / Equity | 1.39 |
| Debt / EBITDA | 6.12 |
| Debt / FCF | n/a |
| Interest Coverage | 0.85 |
Financial Efficiency
Return on equity (ROE) is -22.43%.
| Return on Equity (ROE) | -22.43% |
| Return on Assets (ROA) | -8.18% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $231,101 |
| Profits Per Employee | -$24,961 |
| Employee Count | 643 |
| Asset Turnover | 0.78 |
| Inventory Turnover | 3.98 |
Taxes
In the past 12 months, MariMed has paid $9.41 million in taxes.
| Income Tax | 9.41M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.42% in the last 52 weeks. The beta is 2.87, so MariMed's price volatility has been higher than the market average.
| Beta (1Y) | 2.87 |
| 52-Week Price Change | -36.42% |
| 50-Day Moving Average | 0.27 |
| 200-Day Moving Average | 0.33 |
| Relative Strength Index (RSI) | 55.11 |
| Average Volume (30 Days) | 499,233 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MariMed had revenue of $148.60 million and -$16.05 million in losses. Loss per share was -$0.04.
| Revenue | 148.60M |
| Gross Profit | 59.50M |
| Operating Income | 12.24M |
| Pretax Income | -6.60M |
| Net Income | -16.05M |
| EBITDA | 16.20M |
| EBIT | 7.62M |
| Loss Per Share | -$0.04 |
Balance Sheet
The company has $14.73 million in cash and $99.13 million in debt, giving a net cash position of -$84.39 million or -$0.22 per share.
| Cash & Cash Equivalents | 14.73M |
| Total Debt | 99.13M |
| Net Cash | -84.39M |
| Net Cash Per Share | -$0.22 |
| Equity / Book Value | 71.56M |
| Book Value Per Share | 0.19 |
| Working Capital | 20.57M |
Cash Flow
In the last 12 months, operating cash flow was $7.91 million and capital expenditures -$20.76 million, giving a free cash flow of -$12.85 million.
| Operating Cash Flow | 7.91M |
| Capital Expenditures | -20.76M |
| Free Cash Flow | -12.85M |
| FCF Per Share | -$0.03 |
Margins
Gross margin is 40.04%, with operating and profit margins of 8.23% and -10.80%.
| Gross Margin | 40.04% |
| Operating Margin | 8.23% |
| Pretax Margin | -4.44% |
| Profit Margin | -10.80% |
| EBITDA Margin | 10.90% |
| EBIT Margin | 5.13% |
| FCF Margin | -8.64% |
Dividends & Yields
MariMed does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.53% |
| Shareholder Yield | 1.53% |
| Earnings Yield | -15.47% |
| FCF Yield | -12.38% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MariMed has an Altman Z-Score of 0.79 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.79 |
| Piotroski F-Score | 2 |